Laron dwarfism is associated with resistance to growth hormone (GH). To investigate its genetic basis, we used genetic linkage to test whether the disorder results from a defect in the gene for the human GH receptor. Denaturing gradient gel electrophoresis and sequencing of specific GH-receptor-gene fragments allowed us to characterize specific intragenic DNA markers in 35 control subjects of Mediterranean descent, for use in linkage studies. In two Mediterranean families in which the parents were consanguineous and some of the children had Laron dwarfism, the disease trait and DNA polymorphisms were inherited together. Moreover, an analysis of the GH-receptor-gene RNA transcripts in lymphocytes from one of these families allowed us to identify a thymidine-to-cytosine substitution that generated a serine in place of a phenylalanine at position 96 in the extracellular coding domain of the mature protein. This defect probably affects the receptor adversely and is probably responsible for the lack of plasma GH-binding activity in the patients. This mutation was not found in the GH-receptor genomic sequences of seven unrelated subjects with Laron dwarfism who belonged to different population groups. An analysis of the GH-receptor markers in these patients indicated that different gene frameworks (polymorphic sites within the single gene) were associated with the mutant alleles. We conclude that Laron dwarfism is due to abnormalities in the gene for GH receptor, which may differ from family to family.
Source Information
Service de Biochimie and INSERM, C.H.U. Henri Mondor, Creteil, France.
This article has been cited by other articles:
Fang, P., Girgis, R., Little, B. M., Pratt, K. L., Guevara-Aguirre, J., Hwa, V., Rosenfeld, R. G.
(2008). Growth Hormone (GH) Insensitivity and Insulin-Like Growth Factor-I Deficiency in Inuit Subjects and an Ecuadorian Cohort: Functional Studies of Two Codon 180 GH Receptor Gene Mutations. J. Clin. Endocrinol. Metab.
93: 1030-1037
[Abstract][Full Text]
David, A., Camacho-Hubner, C., Bhangoo, A., Rose, S. J., Miraki-Moud, F., Akker, S. A., Butler, G. E., Ten, S., Clayton, P. E., Clark, A. J. L., Savage, M. O., Metherell, L. A.
(2007). An Intronic Growth Hormone Receptor Mutation Causing Activation of a Pseudoexon Is Associated with a Broad Spectrum of Growth Hormone Insensitivity Phenotypes. J. Clin. Endocrinol. Metab.
92: 655-659
[Abstract][Full Text]
Stoffel, W., Jenke, B., Block, B., Zumbansen, M., Koebke, J.
(2005). Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc. Natl. Acad. Sci. USA
102: 4554-4559
[Abstract][Full Text]
Laron, Z.
(2004). Laron Syndrome (Primary Growth Hormone Resistance or Insensitivity): The Personal Experience 1958-2003. J. Clin. Endocrinol. Metab.
89: 1031-1044
[Abstract][Full Text]
Besson, A., Salemi, S., Gallati, S., Jenal, A., Horn, R., Mullis, P. S., Mullis, P. E.
(2003). Reduced Longevity in Untreated Patients with Isolated Growth Hormone Deficiency. J. Clin. Endocrinol. Metab.
88: 3664-3667
[Abstract][Full Text]
Pantel, J., Grulich-Henn, J., Bettendorf, M., Strasburger, C. J., Heinrich, U., Amselem, S.
(2003). Heterozygous Nonsense Mutation in Exon 3 of the Growth Hormone Receptor (GHR) in Severe GH Insensitivity (Laron Syndrome) and the Issue of the Origin and Function of the GHRd3 Isoform. J. Clin. Endocrinol. Metab.
88: 1705-1710
[Abstract][Full Text]
Kopchick, J. J., Parkinson, C., Stevens, E. C., Trainer, P. J.
(2002). Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly. Endocr. Rev.
23: 623-646
[Abstract][Full Text]
Bachelot, A., Monget, P., Imbert-Bollore, P., Coshigano, K., Kopchick, J. J., Kelly, P. A., Binart, N.
(2002). Growth Hormone Is Required for Ovarian Follicular Growth. Endocrinology
143: 4104-4112
[Abstract][Full Text]
Laron, Z
(2001). Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol. Pathol.
54: 311-316
[Abstract][Full Text]
Mauras, N., Martinez, V., Rini, A., Guevara-Aguirre, J.
(2000). Recombinant Human Insulin-Like Growth Factor I Has Significant Anabolic Effects in Adults with Growth Hormone Receptor Deficiency: Studies on Protein, Glucose, and Lipid Metabolism. J. Clin. Endocrinol. Metab.
85: 3036-3042
[Abstract][Full Text]
(1999). Heritable Disorders of Pituitary Development. J. Clin. Endocrinol. Metab.
84: 4362-4370
[Abstract][Full Text]
BJARNASON, R., SAVAGE, M. O
(1999). Growth hormone insensitivity: a widening diagnosis. Arch. Dis. Child.
81: 378-379
[Full Text]
Woods, K. A., Dastot, F., Preece, M. A., Clark, A. J. L., Postel-Vinay, M.-C., Chatelain, P. G., Ranke, M. B., Rosenfeld, R. G., Amselem, S., Savage, M. O.
(1997). Phenotype: Genotype Relationships in Growth Hormone Insensitivity Syndrome. J. Clin. Endocrinol. Metab.
82: 3529-3535
[Abstract][Full Text]
Ymer, S. I., Stevenson, J. L., Herington, A. C.
(1997). Guinea Pig Serum Contains a Specific High Affinity Growth Hormone-Binding Protein with Novel Ligand Specificity. Endocrinology
138: 3577-3586
[Abstract][Full Text]
Sobrier, M.-L., Dastot, F., Duquesnoy, P., Kandemir, N., Yordam, N., Goossens, M., Amselem, S.
(1997). Nine Novel Growth Hormone Receptor Gene Mutations in Patients with Laron Syndrome. J. Clin. Endocrinol. Metab.
82: 435-437
[Abstract][Full Text]
Baumbach, L., Schiavi, A., Bartlett, R., Perera, E., Day, J., Brown, M. R., Stein, S., Eidson, M., Parks, J. S., Cleveland, W.
(1997). Clinical, Biochemical, and Molecular Investigations of a Genetic Isolate of Growth Hormone Insensitivity (Laron's Syndrome). J. Clin. Endocrinol. Metab.
82: 444-451
[Abstract][Full Text]
Freeth, J. S., Ayling, R. M., Whatmore, A. J., Towner, P., Price, D. A., Norman, M. R., Clayton, P. E.
(1997). Human Skin Fibroblasts as a Model of Growth Hormone (GH) Action in GH Receptor-Positive Laron's Syndrome. Endocrinology
138: 55-61
[Abstract][Full Text]
Woods, K. A., Camacho-Hubner, C., Savage, M. O., Clark, A. J.L.
(1996). Intrauterine Growth Retardation and Postnatal Growth Failure Associated with Deletion of the Insulin-Like Growth Factor I Gene. NEJM
335: 1363-1367
[Full Text]
D'Andrea, A. D.
(1994). Cytokine Receptors in Congenital Hematopoietic Disease. NEJM
330: 839-846
[Full Text]
